Stock Comparison

SNTI vs UNH

Senti Biosciences Inc vs UnitedHealth Group Inc

The Verdict

SNTI takes this one.

Winner

SNTI

Senti Biosciences Inc

2.0

out of 10

Risk Trap

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

N/A

Market Cap

$276.2B

N/A

P/E Ratio

22.9

N/A

Profit Margin

2.7%

N/A

Return on Equity

12.5%

N/A

Debt-to-Equity

0.0

Aggressive

Overall Risk

Moderate-High

2.0

DVR Score

0.3

The Deep Dive

SNTI2.0/10

Senti Biosciences continues to present an extremely high-risk, high-reward profile. Its gene circuit engineering platform holds significant long-term potential within the vast cell and gene therapy market, validated by the IND filing for SENTI-202. This innovative technology could establish a strong competitive moat. However, the company faces severe and immediate financial distress, characterized...

Full SNTI Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.